News

Researchers discover new type of lung cancer

Cold Spring Harbor, NY — Researchers have discovered a new kind of small-cell lung cancer (SCLC). The discovery paves the way for developing personalized medicine approaches to target this previously unnoticed form of the disease. “Cancer is not one thing, it’s actually hundreds of distinct diseases.” This common refrain helps explain the frustrating experience oncologists have … Continued

Read More

SBU’s Benjamin Martin scores first Sohn Research Prize

TBR News Media Up and coming scientists are often stuck in the same position as promising professionals in other fields. To get the funding for research they’d like to do, they need to show results, but to get results, they need funding. Joseph Heller, author of “Catch 22,” would certainly relate. A New York-based philanthropy … Continued

Read More

Study reveals a way to make prostate cancer cells run out of energy and die

Cold Spring Harbor, NY – Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered that cells lacking the tumor-suppressor protein PTEN–a feature of many cancers– are particularly vulnerable to drugs that impair their energy-producing mitochondria. Such drugs induce them to literally eat themselves to death, the research shows. Unlike normal cells, cells without PTEN seem … Continued

Read More

Machine Learning for Building Personalized Cancer Nanomedicines: Interview with Dr. Daniel Heller

Researchers at the Sloan Kettering Institute and the Weill Cornell Graduate School of Medical Sciences in New York have developed a machine learning approach to design personalized nanoparticle therapies for cancer. Personalized cancer therapies aim to provide a treatment that is tailored to the genetic makeup of a patient’s tumor. They can still cause side effects, however, when they … Continued

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2018 Prize for Early-Career Cancer Scientists

NEW YORK, Oct. 2, 2017 /PRNewswire-USNewswire/ — The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2018 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City-based scientists, enabling them to … Continued

Read More

Ackman Commits New Funds for Cancer Research on Vaccines, Drugs

Read More

Why Are More Science Funders Investing in Young Researchers? Here’s Part of the Story

We report frequently enough about research grants and prizes specifically for young investigators—particularly in the biomedical sciences—that some readers have asked why so many foundations make it a point to earmark this early-career funding. What's the obsession with youth? We gray-hairs want to know.

Read More

The case of philanthropy: bringing scientists and philanthropic donors together, for good

By Olivia Tournay Flatto (Disease Models & Mechanisms) – Summary: Philanthropists and scientists share many common interests, and yet they are not familiar with each other’s ways of thinking. This Editorial highlights how to improve their mutual understanding to advance research and life sciences.

Read More

The Logic Behind a Push to Support Underfunded Young Cancer Researchers

Be Sue-Lynn Moses (Inside Philanthropy) – Well, here we are again. It’s late spring, and the Pershing Square Sohn Cancer Research Alliance recently announced the winners of the 2015 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Read More

New York Social Diary: Spring Ahead

On Thursday, May 7th, the Pershing Square Sohn Cancer Research Alliance held its second annual dinner at the Park Avenue Armory, awarding its 2015 Prize in Cancer Research to exceptional innovative scientists in New York City.

Read More